Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development

American Journal of Pathology

Volumn 152, Issue 6, 1998, Pages 1433-1443

  Samaniego, Felipe ^a   Markham, Phillip D ^b   Gendelman, Rita ^f   Watanabe, Yoshiki ^f   Kao, Vivien ^f   Kowalski, Kimberly ^f   Sonnabend, Joseph A ^c   Pintus, Aldo ^d   Gallo, Robert C ^a   Ensoli, Barbara ^e  

^a UNIVERSITY OF MARYLAND   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c Comm Research Initiative on AIDS ^*  (United States)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; EDEMA; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; KAPOSI SARCOMA; MITOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SPINDLE CELL; TUMOR PROMOTION;

ANIMALS; CAPILLARY PERMEABILITY; CELL EXTRACTS; CULTURE MEDIA, CONDITIONED; CYTOKINES; DRUG SYNERGISM; EDEMA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; GUINEA PIGS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18244420373     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Safai B, Johnson KG, Myskowski PL, Koziner B, Yang SY, Cunningham-Rundles S, Godbold JH, Dupont B: The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:744-750
2. Jaffe HW, Choi K, Thomas PA, Haverkos HW, Auerbach DM, Guinan ME, Rogers MF, Spira TJ, Darrow WW, Kramer MA, Friedman SM, Monroe JM, Friedman-Kien AE, Laubenstein LJ, Marmor M, Safai B, Dritz SK, Crispi SJ, Fannin SL, Orkwis JP, Kelter A, Rushing WR, Thacker SB, Curran JW: National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men. I. Epidemiologic results. Ann Intern Med 1983, 99:145-151
3. Havercos HW, Drotman DP, Morgan M: Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med 1985, 312:1518-1520
4. McNutt NS, Fletcher V, Conant MA: Early lesions of Kaposi's sarcoma in homosexual men: an ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 1983, 111:62-77
5. Ruszczak Z, Mayer-Da Silva A, Orfanos CE: Kaposi's sarcoma in AIDS: multicentric angioneoplasia in early skin lesions. Am J Dermatopathol 1987, 9:388-398
6. Zhang Y-M, Bachmann S, Hemmer C, van Lunzen J, von Stemm A, Kern P, Dietrich M, Ziegler R, Waldherr R, Nawroth PP: Vascular origin of Kaposi's sarcoma: expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 1994, 144:51-59
7. Regezi JA, MacPhail LA, Daniels TE, DeSouza YG, Greenspan JS, Greenspan D: Human immunodeficiency virus-associated oral Kaposi's sarcoma. Am J Pathol 1993, 143:240-249
8. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B: Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995, 95:1723-1734
9. Gendelman R, Fiorelli V, Kao V, Gallo RC, Ensoli B: Spindle cells from both AIDS-associated and classical Kaposi's sarcoma (KS) lesions are of endothelial cell origin and present an activated phenotype. AIDS Res Hum Retroviruses 1994, 10:S101
10. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection. Blood 1998, 91:956-967
11. Sirianni MC, Vincenzi L, Fiorelli V, Topino S, Scala E, Uccini S, Angeloni A, Faggioni A, Cerimele D, Cottoni F, Aiuti F, Ensoli B: γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 1998, 91:968-976
12. Ensoli B, Gendelman R, Markham PD, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang H-K, Brady JN, Gallo RC: Synergy between basic fibroblast growth factor and the HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371:674-680
13. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243:223-226
14. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 344:84-86
15. Samaniego F, Gallo RC: Immunopathogenesis of Kaposi's sarcoma. Immunology of HIV Infection. Edited by Gupta S. New York, Plenum Press, 1996, pp 437-450
16. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B: Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 1997, 158:1887-1894
17. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995, 332:1181-1185
18. Cai J, Gill PS, Masood R, Chandrasoma P, Jung B, Law RE, Radka SF: Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994, 145:74-79
19. Oxholm A, Oxholm P, Permin H, Bendtzen K: Epidermal tumour necrosis factor (α) and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. Acta Pathol Microbiol Immunol Scand 1989, 97: 533-538
20. Fan J, Bass HZ, Fahey JL: Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993, 151: 5031-5040
21. DePauli P, Caffau C, D'Andrea M, Tavio M, Tirelli U, Santini G: Serum levels of intercellular adhesion molecule 1 in patients with HIV-1 related Kaposi's sarcoma. J Acquired Immune Defic Syndr 1994, 7:695-699
22. Lepe-Zanuga JL, Mansell PWA, Hersh EM: Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol 1987, 25:1695-1700
23. Hober D, Haque A, Wattre P, Beaucaire G, Mouton Y, Capron A: Production of tumour necrosis factor-α (TNFα) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to a higher cytotoxic activity. Clin Exp Immunol 1989, 78:329-333
24. Vyarkarnam A, Matear P, Meager A, Kelly G, Stanley B, Weller I, Beverley P: Altered production of tumour necrosis factors α and β and interferon γ by HIV-infected individuals. Clin Exp Immunol 1991, 84:109-115
25. Schlesinger M, Chu FN, Badamchian M, Jiang JD, Roboz JP, Goldstein AL, Bekesi JG: A distinctive form of soluble CD8 is secreted by stimulated CD8+ cells in HIV-1-infected and high risk individuals. Clin Immunol Immunopathol 1994, 73:252-260
26. Mitsuyasu RT: Clinical aspects of AIDS-related Kaposi's sarcoma. Curr Opin Oncol 1993, 5:835-844
27. Krigel RL, Odajnyk CM, Laubenstein LJ, Ostreicher R, Wernz J, Vilcek J, Rubinstein P, Friedman-Kien AE: Therapeutic trial of interferon-γ in patients with epidemic Kaposi's sarcoma. J Biol Response Modif 1985, 4:358-364
28. Krigel RL, Padavic-Shaller KA, Rudolph AR, Poiesz BJ, Comis RL: Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and γ-interferon: results of a phase 2 study. J Biol Response Modif 1989, 8:359-365
29. Aboulafia D, Miles SA, Saks SR, Mitsuyasu RT: Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acquired Immune Defic Syndr 1989, 2:54-58
30. Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B: Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992, 149:3727-3734
31. Samaniego F, Markham PD, Gallo RC, Ensoli B: Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol 1995, 154:3582-3592
32. Ensoli B, Markham PD, Kao V, Barillari G, Fiorelli V, Gendelman R, Raffeld M, Zon G, Gallo RC: Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J Clin Invest 1994, 94:1736-1737
33. Xerri L, Hassoun J, Planche J, Guigou V, Grob J-J, Parc P, Birnbaum D, deLapeyriere O: Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am J Pathol 1991, 138:9-15
34. Ruszczak Z, Mayer da Silva A, Orfanos CE: Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica 1987, 175:270-279
35. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvork HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992, 176:1375-1379
36. Detmar M, Brown LF, Claffey KP, Yeo K-T, Kocher O, Jackman RW, Berse B, Dvork HF: Overexpression of vascular permeability factor/ vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994, 180:1141-1146
37. Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tshachler E, Albini S, Stürzl M: Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996, 149:1851-1869
38. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS: Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 1997, 94:979-984
39. Nakamura S, Murakami-Mori K, Rao N, Weich HA, Rajeev B. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J Immunol 1997, 158: 4992-5001
40. Weindel K, Marme D, Weich HA: AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 1992, 183:1167-1174
41. Miles SA, Martinez-Maza O, Rezai A, Magpartay L, Kishomoto T, Nakamura S, Radka SF, Linsley PS: Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992, 255:1432-1434
42. Daniel WW: Biostatistics: A Foundation for Analysis in the Health Sciences. New York, Edited by Wiley and Sons. 1978, pp 138-140
43. Kim KJ, Li B, Houck K, Winer J, Ferrara N: The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing antibodies. Growth Factors 1992, 7:53-64
44. Stürzl M, Brandstetter H, Zietz C, Eisenburg B, Raivich G, Gearing DP, Brockmeyer NH, Hofschneider PH: Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene 1995, 10:2007-2016
45. Tsai J-C, Goldman CK, Gillespie GY: Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB and bFGF. J Neurosurg 1995, 82:864-873
46. Wangoo A, Taylor IK, Haynes AR, Shaw RJ: Up-regulation of alveolar macrophage platelet-derived growth factor-B (PDGF-B) mRNA by interferon-γ from Mycobacterium tuberculosis antigen (PPD)-stimulated lymphocytes. Clin Exp Immunol 1993, 94:43-50
47. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J Biol Chem 1995, 270:12607-12613
48. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992, 267:26031-26037
49. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991, 5:1806-1814
50. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994, 367:576-579
51. Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992, 189:824-831
52. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69:508-516
53. Brown LF, Tognazzi K, Dvork HF, Harrist TJ: Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996, 148:1065-1074
54. Ensoli B, Gallo RC: AIDS-associated Kaposi's sarcoma: a new perspective of its pathogenesis and treatment. Proc Assoc Am Physicians 1995, 107:8-18